8-K: Agilent Technologies Reports Solid Q1 2025 Results, Confirms Core Growth and EPS Guidance

Agilent Technologies announces first-quarter fiscal year 2025 results with revenue of $1.68 billion, representing 1.4% reported growth and 1.2% core growth, while maintaining full-year outlook.

Summary

• Agilent Technologies reported its first-quarter fiscal year 2025 financial results, with revenue reaching $1.68 billion.
• This represents a 1.4% increase on a reported basis and a 1.2% increase on a core basis compared to the first quarter of 2024.
• GAAP net income was $318 million, resulting in earnings per share (EPS) of $1.11, a 6% decrease from the previous year.
• Non-GAAP net income was $377 million, with an EPS of $1.31, a 2% increase from the first quarter of 2024.
• The company's full-year revenue outlook remains in the range of $6.68 billion to $6.76 billion, indicating a 2.6% to 3.8% reported growth and 2.5% to 3.5% core growth.
• Non-GAAP EPS is projected to be between $5.54 and $5.61 per share for the full year.
• For the second quarter, revenue is expected to be in the range of $1.61 billion to $1.65 billion, reflecting a 2.4% to 4.9% reported growth and 2.5% to 5.0% core growth.
• Second-quarter non-GAAP EPS is anticipated to be in the range of $1.25 to $1.28 per share.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the solid Q1 results and maintained guidance, although GAAP net income decreased.

Positives

• Agilent's revenue increased by 1.4% on a reported basis and 1.2% on a core basis.
• Non-GAAP EPS increased by 2% compared to the first quarter of the previous year.
• The company is maintaining its core growth and EPS expectations for the year.
• The Life Sciences and Diagnostics Markets Group (LDG) and Agilent CrossLab Group (ACG) both reported revenue increases.

Negatives

• GAAP net income decreased by 6% compared to the first quarter of the previous year.
• The Applied Markets Group (AMG) reported a revenue decrease of 4% reported and 2% core year-over-year.

Risks

• Unforeseen changes in customer businesses could impact Agilent's results.
• Changes in demand for products, technologies, and services pose a risk.
• Currency market fluctuations could affect financial performance.
• Customer purchasing decisions and timing are uncertain.
• The company faces risks related to integration and restructuring activities.
• Geopolitical uncertainties and global economic conditions could impact operations.
• The company's ability to successfully comply with complex regulations is a risk.

Future Outlook

Agilent expects full-year revenue to be in the range of $6.68 billion to $6.76 billion, with non-GAAP EPS between $5.54 and $5.61 per share; Q2 revenue is expected to be in the range of $1.61 billion to $1.65 billion, with non-GAAP EPS between $1.25 and $1.28 per share.

Management Comments

• The Agilent team delivered better than our expectations in Q1.
• As a result of a solid start to the year, we're maintaining our core growth and EPS expectations for the year.
• We have moved from planning to execution on our market-first strategy we introduced at our Analyst and Investor Day and are seeing the early benefits of our Ignite Transformation to become nimbler and make decisions faster in service to our customers.

Industry Context

Agilent's focus on analytical and clinical laboratory technologies positions it within a competitive landscape where innovation and customer service are key differentiators.

Comparison to Industry Standards

• Agilent competes with companies like Thermo Fisher Scientific, Danaher, and PerkinElmer in the analytical and clinical laboratory technologies market.
• Agilent's revenue growth of 1.4% is within the expected range for companies in this sector, but investors will be looking for continued growth in future quarters.
• Operating margins for each segment are in line with industry standards.

Stakeholder Impact

• Shareholders can expect continued focus on growth and profitability.
• Employees will be involved in the ongoing Ignite Transformation.
• Customers should benefit from Agilent's market-first strategy and improved decision-making.

Next Steps

• Agilent's management will present additional details regarding the company's first-quarter 2025 financial results on a conference call with investors.

Key Dates